Cresset Asset Management, LLC Bristol Myers Squibb CO Transaction History

Cresset Asset Management, LLC

$20.6 Billion
Q1 2024

A detailed history of Cresset Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cresset Asset Management, LLC holds 436,413 shares of BMY stock, worth $17.5 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

436,413

Previous 200 218106.5%

Holding current value

$17.5 Million

Previous $10,000 236560.0%

% of portfolio

0.11%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $4.77 Million - $5.41 Million	99,360 Added 29.48%	436,413 $23.7 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $2.9 Million - $3.46 Million	-59,888 Reduced 15.09%	337,053 $17.3 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $116,879 - $130,689	-2,019 Reduced 0.51%	396,941 $23 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $20.8 Million - $23.1 Million	327,148 Added 455.56%	398,960 $25.5 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $19.6 Million - $22.3 Million	-298,605 Reduced 80.61%	71,812 $4.98 Million

Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $613,032 - $725,917	-8,952 Reduced 2.36%	370,417 $26.6 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $972 - $574,916	-7,482 Reduced 1.93%	379,369 $27 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $86,780 - $95,576	1,195 Added 0.31%	386,851 $30 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $508,193 - $609,369	-8,266 Reduced 2.1%	385,656 $28.4 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $722,074 - $841,769	13,464 Added 3.54%	393,922 $24.6 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $180,586 - $211,534	3,052 Added 0.81%	380,458 $22.7 Million
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $19.4 Million - $21.2 Million	314,093 Added 496.1%	377,406 $25.2 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $19.1 Million - $21.5 Million	-321,861 Reduced 83.56%	63,313 $4.03 Million
Q4 2020 Feb 11, 2021	SELL	$57.74 - $65.43 $726,542 - $823,305	-12,583 Reduced 3.16%	385,174 $24.1 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $486,030 - $538,585	-8,463 Reduced 2.08%	397,757 $24 Million
Q2 2020 Aug 04, 2020	BUY	$54.82 - $64.09 $306,827 - $358,711	5,597 Added 1.4%	406,220 $23.9 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $224,065 - $325,619	4,829 Added 1.22%	400,623 $22.3 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $2.92 Million - $3.81 Million	59,404 Added 17.66%	395,794 $27.2 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $87,592 - $103,854	2,048 Added 0.61%	336,390 $17.1 Million
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $1.27 Million - $1.41 Million	28,483 Added 9.31%	334,342 $15.2 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $795,961 - $949,085	17,641 Added 6.12%	305,859 $14.6 Million
Q4 2018 May 21, 2019	BUY	$48.76 - $63.23 $14.1 Million - $18.2 Million	288,218 New	288,218 $15 Million

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $85.2B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC Bristol Myers Squibb CO Transaction History